ASCO 2019: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective
Treatment with dabrafenib and trametinib, a drug combination designed to target cancers that harbour certain…
Browsing: dabrafenib
Patients with rare, incurable digestive tract cancers respond to new drug combination
Patients with rare, but incurable cancers of the digestive tract have responded well to a…
AACR 2018: How do melanoma cells survive drug treatment long enough to acquire drug resistance?
Cancer often picks up genetic changes that allow it to resist treatment. But this takes…
ESMO 2017: Combination Targeted Adjuvant Therapy Doubles Relapse-free Survival in Stage III Melanoma
Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage…